英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
caffeic acid glucoside |
咖啡酰葡萄糖苷 |
892501-29-0 |
詳細(xì)
|
2,2',5-Tribromobiphenyl |
2,2,5-三溴聯(lián)苯 |
59080-34-1 |
詳細(xì)
|
PBB No. 26 |
2,3',5-三溴聯(lián)苯 |
59080-35-2 |
詳細(xì)
|
3,4,5-Trichlorophenol acetate |
3,4,5-三氯苯酚乙酸酯 |
59190-61-3 |
詳細(xì)
|
Ergosinine |
異麥角生鹼 |
596-88-3 |
詳細(xì)
|
2,6-Diethylnaphthalene |
2,6-二乙基萘 |
59919-41-4 |
詳細(xì)
|
PBB-No. 49 |
2,2',4,5'-四溴聯(lián)苯 |
60044-24-8 |
詳細(xì)
|
5,10,15,20-Tetraoxatetracosane-1,24-diol |
5,10,15,20-四氧辛酸酯-1,24-二醇 |
61136-08-1 |
詳細(xì)
|
1,2-Dichlorobutane |
1,2-二氯丁烷 |
616-21-6 |
詳細(xì)
|
PCB No. 50 |
2,2',4,6-四氯聯(lián)苯 |
62796-65-0 |
詳細(xì)
|
Testosterone-d4 |
[2H4] - 睪酮 |
638163-36-7 |
詳細(xì)
|
4-Cyano-4'-undecylbiphenyl |
4-氰基-4'-十一烷基聯(lián)苯 |
65860-74-4 |
詳細(xì)
|
Ivuxolimab |
IVUXOLIMAB (艾沃利單抗 ) |
2225940-98-5 |
詳細(xì)
|
Balstilimab |
BALSTILIMAB (巴替利單抗 ) |
2230167-06-1 |
詳細(xì)
|
Ecromeximab |
Kw-2871 |
292819-64-8 |
詳細(xì)
|
Derlotuximab |
Cotara (9CI) |
340013-96-9 |
詳細(xì)
|
Tacatuzumab |
Yttrium (90Y) Tacatuzumab Tetraxetan |
476413-07-7 |
詳細(xì)
|
Ertumaxomab |
ertumaxomab |
509077-99-0 |
詳細(xì)
|
Besilesomab |
Besilesomab |
537694-98-7 |
詳細(xì)
|
Mapatumumab |
Mapatumumab |
658052-09-6 |
詳細(xì)
|
Naptumomab Estafenatox |
埃托-那普妥莫單抗 |
676258-98-3 |
詳細(xì)
|
HuCC49 |
|
823788-82-5 |
詳細(xì)
|
Romosozumab |
ROMOSOZUMAB |
909395-70-6 |
詳細(xì)
|
Alacizumab |
培戈-阿拉賽珠單抗 |
934216-54-3 |
詳細(xì)
|
Oportuzumab |
Oportuzumab Monatox |
945228-48-8 |
詳細(xì)
|
Thalidomide-4-O-CH2-COO(t-Bu) |
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)氧基)乙酸叔丁酯 |
1950635-36-5 |
詳細(xì)
|
Thalidomide-NH-(CH2)2-NH-Boc |
沙利度胺-NH-C2-NH-Boc |
1957235-57-2 |
詳細(xì)
|
Thalidomide-NH-CH2-COO(t-Bu) |
沙利度胺-NH-C2-NH-COO(T-BU) |
2093386-23-1 |
詳細(xì)
|
JYS001 |
標(biāo)準(zhǔn)品RN1331 |
2111829-84-4 |
詳細(xì)
|
Thalidomide-4-NH-PEG1-NH-Boc |
沙利度胺-NH-PEG1-NH-BOC |
2154342-17-1 |
詳細(xì)
|
JYS007 |
L-PROLINAMIDE, N-(12,12-DIMETHYL-1,10-DIOXO-3,6,11-TRIOXA-9-AZATRIDEC-1-YL)-3-METHYL-L-VALYL-4-HYDRO |
2162120-75-2 |
詳細(xì)
|
JYS005 |
L-PROLINAMIDE, N-[8-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-OXOOCTYL]-3-METHYL-L-VALYL-4-HYDROXY-N-[ |
2306389-02-4 |
詳細(xì)
|
VH032-NH-CO-CH2-Br |
|
2379404-33-6 |
詳細(xì)
|
JYS004 |
VH032-BOC-丁胺 |
2412055-00-4 |
詳細(xì)
|
Thalidomide-5-NH-CH2-COO(t-Bu) |
THALIDOMIDE-5-NH-CH2-COO(T-BU) |
2412056-28-9 |
詳細(xì)
|
Thalidomide-4-NH-PEG1-NH2 TFA |
1H-ISOINDOLE-1,3(2H)-DIONE, 4-[[2-(2-AMINOETHOXY)ETHYL]AMINO]-2-(2,6-DIOXO-3-PIPERIDINYL)-, 2,2,2-TR |
2490499-21-1 |
詳細(xì)
|
Thalidomide-5-O-CH2-COO(t-Bu) |
ACETIC ACID, 2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-5-YL]OXY]-, 1,1-DIME |
2682112-10-1 |
詳細(xì)
|
JYS008 |
VH032-甲基-BOC |
2827750-24-1 |
詳細(xì)
|
JYS009 |
VH032-丙基-BOC |
2827750-25-2 |
詳細(xì)
|
Glucuronic Acid |
葡糖醛酸 |
576-37-4 |
詳細(xì)
|
4'-Cyano-4-nonyloxybiphenyl |
9OCB |
58932-13-1 |
詳細(xì)
|
Roledumab |
ROLEDUMAB ( 羅來(lái)度單抗 ) |
1174008-79-7 |
詳細(xì)
|
Narnatumab |
Narnatumab |
1188275-92-4 |
詳細(xì)
|
Pateclizumab |
帕替組單抗 |
1202526-59-7 |
詳細(xì)
|
Refanezumab |
Refanezumab |
1233953-61-1 |
詳細(xì)
|
Ifabotuzumab |
IFABOTUZUMAB |
1234137-51-9 |
詳細(xì)
|
Indatuximab |
Indatuximab Ravtansine |
1238517-16-2 |
詳細(xì)
|
Actoxumab |
Actoxumab |
1245634-25-6 |
詳細(xì)
|
Radretumab |
RADRETUMAB ( 雷曲妥單抗 ) |
1253180-81-2 |
詳細(xì)
|
Imciromab |
英西單抗 |
126132-83-0 |
詳細(xì)
|
Coltuximab |
Coltuximab Ravtansine |
1269764-99-9 |
詳細(xì)
|
Perakizumab |
培拉凱珠單抗 |
1331830-76-2 |
詳細(xì)
|
Olendalizumab |
Olendalizumab |
1337966-73-0 |
詳細(xì)
|
Dinutuximab |
dinutuximab |
1363687-32-4 |
詳細(xì)
|
Otlertuzumab |
Otlertuzumab |
1372645-37-8 |
詳細(xì)
|
Biciromab |
Biciromab |
138783-13-8 |
詳細(xì)
|
Erlizumab |
厄利珠單抗 |
211323-03-4 |
詳細(xì)
|
Vandortuzumab |
Vandortuzumab Vedotin |
1471985-92-8 |
詳細(xì)
|
Dezamizumab |
Dezamizumab |
1662664-56-3 |
詳細(xì)
|
Ieramilimab |
埃拉利單抗 |
2137049-37-5 |
詳細(xì)
|
Capromab |
CAPROMAB |
145464-28-4 |
詳細(xì)
|
Landogrozumab |
Landogrozumab |
1391726-30-9 |
詳細(xì)
|
Vadastuximab |
Vadastuximab |
1436390-63-4 |
詳細(xì)
|
Nofetumomab |
Merpentan |
165942-79-0 |
詳細(xì)
|
Denintuzumab |
Denintuzumab Mafodotin |
1399672-02-6 |
詳細(xì)
|
Zolimomab |
阿佐莫單抗 |
141483-72-9 |
詳細(xì)
|
Arcitumomab |
阿西莫單抗 |
154361-48-5 |
詳細(xì)
|
Ontamalimab |
Ontamalimab |
2098790-40-8 |
詳細(xì)
|
Cibisatamab |
賽必妥單抗 |
2101242-53-7 |
詳細(xì)
|
Cusatuzumab |
古妥珠單抗 |
1399546-01-0 |
詳細(xì)
|
Tabituximab |
Tabituximab |
1644134-10-0 |
詳細(xì)
|
Domagrozumab |
Domagrozumab |
1629605-31-7 |
詳細(xì)
|
Apamistamab |
Iodine (131I) Apamistamab |
2097132-02-8 |
詳細(xì)
|
Sirtratumab |
Sirtratumab |
1824663-82-2 |
詳細(xì)
|
Evinacumab |
Evinacumab |
1446419-85-7 |
詳細(xì)
|
Lintuzumab |
Lintuzumab |
166089-32-3 |
詳細(xì)
|
Samrotamab |
Samrotamab |
2052591-32-7 |
詳細(xì)
|
Tamrintamab |
TAMRINTAMAB (他林妥單抗 ) |
2148325-59-9 |
詳細(xì)
|
Tositumomab |
bexxar |
208921-02-2 |
詳細(xì)
|
Oregovomab |
OregovoMab |
213327-37-8 |
詳細(xì)
|
Clivatuzumab |
Clivatuzumab Tetraxetan |
1462876-11-4 |
詳細(xì)
|
Bimagrumab |
Bimagrumab |
1356922-05-8 |
詳細(xì)
|
JYS006 |
L-PROLINAMIDE, N-[2-[2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ETHOXY]ACETYL]-3-METHYL-L-VALYL-4-HYDROX |
2409007-41-4 |
詳細(xì)
|
JYS003 |
L-PROLINAMIDE, N-[4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-OXOBUTYL]-3-METHYL-L-VALYL-4-HYDROXY-N-[ |
2361119-87-9 |
詳細(xì)
|
Thalidomide-4-NH-PEG3-NH-Boc |
(2-(2-(2-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚-4-基)氨基)乙氧基)乙氧基)乙氧基)乙基叔丁基)氨基甲酸酯 |
2204246-03-5 |
詳細(xì)
|
Thalidomide-4-NH-PEG2-COO(t-Bu) |
PROPANOIC ACID, 3-[2-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]E |
2140807-16-3 |
詳細(xì)
|
Thalidomide-NH-(CH2)3-NH-Boc |
沙利度胺-NH-C3-NH-BOC |
2093386-36-6 |
詳細(xì)
|
Stamulumab |
司他莫魯 |
705287-60-1 |
詳細(xì)
|
Sudan Black B Impurity 1 |
蘇旦黑B雜質(zhì)1 |
65322-64-7 |
詳細(xì)
|
6-Nitrobenz[a]pyrene |
6-硝基苯并(A)芘 |
63041-90-7 |
詳細(xì)
|
Carbophenothion-methyl-sulfone |
甲基三硫磷砜, 10ΜG /ΜL于環(huán)己烷 |
62059-34-1 |
詳細(xì)
|
2,3,4-Trichlorophenol acetate |
2,3,4-三氯苯酚乙酸酯 |
61925-89-1 |
詳細(xì)
|
PBB No. 53 |
2,2,5,6-四溴聯(lián)苯 |
60044-25-9 |
詳細(xì)
|
Nacolomab Tafenatox |
Nacolomabtafenatox |
150631-27-9 |
詳細(xì)
|
Satumomab |
沙妥莫單抗 |
144058-40-2 |
詳細(xì)
|
JYS002 |
標(biāo)準(zhǔn)品RN1332 |
1448189-66-9 |
詳細(xì)
|
Clothianidin-urea |
Urea, N-[(2-chloro-5-thiazolyl)methyl]-N'-methyl- |
634192-72-6 |
詳細(xì)
|
VH032-NH-CO-CH2-NHBoc |
VH032-BOC-氨基 |
2010986-19-1 |
詳細(xì)
|
Altumomab |
阿妥莫單抗 |
156586-92-4 |
詳細(xì)
|
Thalidomide-4-NH-PEG1-COO(t-Bu) |
PROPANOIC ACID, 3-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]ETHO |
2140807-19-6 |
詳細(xì)
|